3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gynecologic
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
3
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Stomach Neoplasms
1
Rectal Neoplasms
1
Ovarian Carcinosarcoma
1
Oropharyngeal Neoplasms
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Laryngeal Diseases
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Squamous Cell
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
niraparib
1
dostarlimab
1
Antineoplastic Agents
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Ovarian Carcinosarcoma
×
dostarlimab
×
30 days
×
Clear all
NCT03651206
2026-06-01
ROCSAN
ARCAGY/ GINECO GROUP
Phase 2/3
Recruiting
138 enrolled